Sarena Francis Willard 4
4 · Apexigen, Inc. · Filed May 25, 2023
Insider Transaction Report
Form 4
Apexigen, Inc.APGN
Sarena Francis Willard
Chief Operating Officer
Transactions
- Award
Common Stock
2023-05-23+150,000→ 183,084 total - Tax Payment
Common Stock
2023-05-23$0.40/sh−20,748$8,299→ 162,336 total
Footnotes (2)
- [F1]The reported shares are represented by restricted stock units, or RSUs. Upon signing of the merger agreement between the Issuer and Pyxis Oncology, Inc. dated May 23, 2023, 60,000 RSUs vested. The remaining 90,000 RSUs vest on the earlier of (i) the closing of the merger or (ii) September 30, 2023.
- [F2]The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs.